[Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
In a multicentre, single-blind study, the bronchospasmolytic effect of a single oral dose of tulobuterol 2.0 mg and of fenoterol 2.5 mg was compared in 26 patients suffering from reversible airways obstruction. The bronchospasmolysis achieved with the oral application of tulobuterol and fenoterol is qualitatively satisfactory and reliable, the effect of tulobuterol persisting for a longer period than that of fenoterol.
Morr
H
H
Klinik für Lungen- und Bronchialerkrankungen Waldhof Elgershausen, Greifenstein.
Nink
M
M
Ferlinz
R
R
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D005280:Fenoterol / Q000008:administration & dosage*; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D013726:Terbutaline / Q000008:administration & dosage / Q000031:analogs & derivatives*
D001993:Bronchodilator Agents; D005280:Fenoterol; C010809:tulobuterol; D013726:Terbutaline
Orale Therapie mit Beta-2-Sympathomimetika: Vergleichende Studie zur bronchospasmolytischen Wirkung von Tulobuterol und Fenoterol bei Patienten mit reversibler Atemwegsobstruktion.